Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model

Sumanta Kumar Goswami, Bora Inceoglu, Jun Yang, Debin Wan, Sean D. Kodani, Carlos Antonio Trindade da Silva, Christophe Morisseau, Bruce D. Hammock

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids (EETs) are potent endogenous analgesic metabolites produced from arachidonic acid by cytochrome P450s (P450s). Metabolism of EETs by soluble epoxide hydrolase (sEH) reduces their activity, while their stabilization by sEH inhibition decreases both inflammatory and neuropathic pain. Here, we tested the complementary hypothesis that increasing the level of EETs through induction of P450s by omeprazole (OME), can influence pain related signaling by itself, and potentiate the anti-hyperalgesic effect of sEH inhibitor. Rats were treated with OME (100mg/kg/day, p.o., 7days), sEH inhibitor TPPU (3mg/kg/day, p.o.) and OME (100mg/kg/day, p.o., 7days)+TPPU (3mg/kg/day, p.o., last 3days of OME dose) dissolved in vehicle PEG400, and their effect on hyperalgesia (increased sensitivity to pain) induced by PGE2 was monitored. While OME treatment by itself exhibited variable effects on PGE2 induced hyperalgesia, it strongly potentiated the effect of TPPU in the same assay. The significant decrease in pain with OME+TPPU treatment correlated with the increased levels of EETs in plasma and increased activities of P450 1A1 and P450 1A2 in liver microsomes. The results show that reducing catabolism of EETs with a sEH inhibitor yielded a stronger analgesic effect than increasing generation of EETs by OME, and combination of both yielded the strongest pain reducing effect under the condition of this study.

Original languageEnglish (US)
Pages (from-to)419-427
Number of pages9
JournalToxicology and Applied Pharmacology
Volume289
Issue number3
DOIs
StatePublished - Dec 15 2015

Fingerprint

Epoxide Hydrolases
Omeprazole
Dinoprostone
Pain
Hyperalgesia
Analgesics
Cohort Effect
Neuralgia
Liver Microsomes
Cytochromes
Metabolites
Arachidonic Acid
Metabolism
Liver
Rats
Assays
Stabilization
Plasmas
Acids
Therapeutics

Keywords

  • Cytochrome P450 1A
  • Epoxyeicosatrienoic acid
  • Omeprazole
  • Prostaglandin E induced hyperalgesia
  • SEH inhibitor TPPU
  • Time dependent P450 induction

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Goswami, S. K., Inceoglu, B., Yang, J., Wan, D., Kodani, S. D., da Silva, C. A. T., ... Hammock, B. D. (2015). Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model. Toxicology and Applied Pharmacology, 289(3), 419-427. https://doi.org/10.1016/j.taap.2015.10.018

Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model. / Goswami, Sumanta Kumar; Inceoglu, Bora; Yang, Jun; Wan, Debin; Kodani, Sean D.; da Silva, Carlos Antonio Trindade; Morisseau, Christophe; Hammock, Bruce D.

In: Toxicology and Applied Pharmacology, Vol. 289, No. 3, 15.12.2015, p. 419-427.

Research output: Contribution to journalArticle

Goswami, SK, Inceoglu, B, Yang, J, Wan, D, Kodani, SD, da Silva, CAT, Morisseau, C & Hammock, BD 2015, 'Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model', Toxicology and Applied Pharmacology, vol. 289, no. 3, pp. 419-427. https://doi.org/10.1016/j.taap.2015.10.018
Goswami, Sumanta Kumar ; Inceoglu, Bora ; Yang, Jun ; Wan, Debin ; Kodani, Sean D. ; da Silva, Carlos Antonio Trindade ; Morisseau, Christophe ; Hammock, Bruce D. / Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model. In: Toxicology and Applied Pharmacology. 2015 ; Vol. 289, No. 3. pp. 419-427.
@article{98e0c304f0ff423b89f2cabcfb23e98b,
title = "Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model",
abstract = "Epoxyeicosatrienoic acids (EETs) are potent endogenous analgesic metabolites produced from arachidonic acid by cytochrome P450s (P450s). Metabolism of EETs by soluble epoxide hydrolase (sEH) reduces their activity, while their stabilization by sEH inhibition decreases both inflammatory and neuropathic pain. Here, we tested the complementary hypothesis that increasing the level of EETs through induction of P450s by omeprazole (OME), can influence pain related signaling by itself, and potentiate the anti-hyperalgesic effect of sEH inhibitor. Rats were treated with OME (100mg/kg/day, p.o., 7days), sEH inhibitor TPPU (3mg/kg/day, p.o.) and OME (100mg/kg/day, p.o., 7days)+TPPU (3mg/kg/day, p.o., last 3days of OME dose) dissolved in vehicle PEG400, and their effect on hyperalgesia (increased sensitivity to pain) induced by PGE2 was monitored. While OME treatment by itself exhibited variable effects on PGE2 induced hyperalgesia, it strongly potentiated the effect of TPPU in the same assay. The significant decrease in pain with OME+TPPU treatment correlated with the increased levels of EETs in plasma and increased activities of P450 1A1 and P450 1A2 in liver microsomes. The results show that reducing catabolism of EETs with a sEH inhibitor yielded a stronger analgesic effect than increasing generation of EETs by OME, and combination of both yielded the strongest pain reducing effect under the condition of this study.",
keywords = "Cytochrome P450 1A, Epoxyeicosatrienoic acid, Omeprazole, Prostaglandin E induced hyperalgesia, SEH inhibitor TPPU, Time dependent P450 induction",
author = "Goswami, {Sumanta Kumar} and Bora Inceoglu and Jun Yang and Debin Wan and Kodani, {Sean D.} and {da Silva}, {Carlos Antonio Trindade} and Christophe Morisseau and Hammock, {Bruce D.}",
year = "2015",
month = "12",
day = "15",
doi = "10.1016/j.taap.2015.10.018",
language = "English (US)",
volume = "289",
pages = "419--427",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model

AU - Goswami, Sumanta Kumar

AU - Inceoglu, Bora

AU - Yang, Jun

AU - Wan, Debin

AU - Kodani, Sean D.

AU - da Silva, Carlos Antonio Trindade

AU - Morisseau, Christophe

AU - Hammock, Bruce D.

PY - 2015/12/15

Y1 - 2015/12/15

N2 - Epoxyeicosatrienoic acids (EETs) are potent endogenous analgesic metabolites produced from arachidonic acid by cytochrome P450s (P450s). Metabolism of EETs by soluble epoxide hydrolase (sEH) reduces their activity, while their stabilization by sEH inhibition decreases both inflammatory and neuropathic pain. Here, we tested the complementary hypothesis that increasing the level of EETs through induction of P450s by omeprazole (OME), can influence pain related signaling by itself, and potentiate the anti-hyperalgesic effect of sEH inhibitor. Rats were treated with OME (100mg/kg/day, p.o., 7days), sEH inhibitor TPPU (3mg/kg/day, p.o.) and OME (100mg/kg/day, p.o., 7days)+TPPU (3mg/kg/day, p.o., last 3days of OME dose) dissolved in vehicle PEG400, and their effect on hyperalgesia (increased sensitivity to pain) induced by PGE2 was monitored. While OME treatment by itself exhibited variable effects on PGE2 induced hyperalgesia, it strongly potentiated the effect of TPPU in the same assay. The significant decrease in pain with OME+TPPU treatment correlated with the increased levels of EETs in plasma and increased activities of P450 1A1 and P450 1A2 in liver microsomes. The results show that reducing catabolism of EETs with a sEH inhibitor yielded a stronger analgesic effect than increasing generation of EETs by OME, and combination of both yielded the strongest pain reducing effect under the condition of this study.

AB - Epoxyeicosatrienoic acids (EETs) are potent endogenous analgesic metabolites produced from arachidonic acid by cytochrome P450s (P450s). Metabolism of EETs by soluble epoxide hydrolase (sEH) reduces their activity, while their stabilization by sEH inhibition decreases both inflammatory and neuropathic pain. Here, we tested the complementary hypothesis that increasing the level of EETs through induction of P450s by omeprazole (OME), can influence pain related signaling by itself, and potentiate the anti-hyperalgesic effect of sEH inhibitor. Rats were treated with OME (100mg/kg/day, p.o., 7days), sEH inhibitor TPPU (3mg/kg/day, p.o.) and OME (100mg/kg/day, p.o., 7days)+TPPU (3mg/kg/day, p.o., last 3days of OME dose) dissolved in vehicle PEG400, and their effect on hyperalgesia (increased sensitivity to pain) induced by PGE2 was monitored. While OME treatment by itself exhibited variable effects on PGE2 induced hyperalgesia, it strongly potentiated the effect of TPPU in the same assay. The significant decrease in pain with OME+TPPU treatment correlated with the increased levels of EETs in plasma and increased activities of P450 1A1 and P450 1A2 in liver microsomes. The results show that reducing catabolism of EETs with a sEH inhibitor yielded a stronger analgesic effect than increasing generation of EETs by OME, and combination of both yielded the strongest pain reducing effect under the condition of this study.

KW - Cytochrome P450 1A

KW - Epoxyeicosatrienoic acid

KW - Omeprazole

KW - Prostaglandin E induced hyperalgesia

KW - SEH inhibitor TPPU

KW - Time dependent P450 induction

UR - http://www.scopus.com/inward/record.url?scp=84947798955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947798955&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2015.10.018

DO - 10.1016/j.taap.2015.10.018

M3 - Article

C2 - 26522832

AN - SCOPUS:84947798955

VL - 289

SP - 419

EP - 427

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -